药智官方微信
药智官方微博
山东京卫制药有限公司成立于1993年，座落于泰山脚下的泰安国家高新区。公司以创新为驱动力，专注于呼吸领域吸入制剂和精神神经领域用药的研发与生产。公司是国家高新技术企业、吸入药物山东省工程研究中心。公司深耕吸入制剂30年，积累了丰富的吸入制剂研发、生产经验。吸入制剂研发、生产能力涵盖吸入气雾剂、吸入粉雾剂、吸入液体制剂、鼻用喷雾剂，公司已有十五个品规吸入制剂在国内上市，其中有多个国内首仿药和独家产品，保持领先的市场份额。公司产品在美国、澳大利亚、新西兰等全球70多个国家上市。公司现有气雾剂、原料药、综合制剂三个生产厂区，在北京、济南有三个研发子公司。
[更多详情]
可提供吸入气雾剂、吸入粉雾剂、吸入液体制剂、鼻喷雾剂CDMO/CMO服务，可已有项目转让或二次开发，可根据客户立项定制CDMO服务，可接受上述产品CMO业务
康替唑胺原料药，CAS112968-42-9
康替唑胺起始物料，N-3-异恶唑氨基甲酸叔丁酯,CAS264600-97-7
康替唑胺中间体4，1-（4-氨基-2,3,6-三氟苯基）-2,3-二氢吡啶-4（1H）-酮, CAS1112968-95-2
可提供、定制多种原料药杂质对照品：
| 产品编号 | 中文名称 | 英文名称 | CAS号 | 商铺分类 |
| 01-001 | 异丙基托品醇 | endo-8-isopropyl-8-azabicyclo[3.2.1]octan-3-ol | 3423-25-4 | 杂质对照品-异丙托溴铵 |
| 01-002 | N-异丙基去甲阿托品 | (1R,3r,5S)-8-isopropyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate | 22235-81-0 | 杂质对照品-异丙托溴铵 |
| 01-003 | （1R，3R，5S）-8-异丙基-8-氮杂双环[3.2.1]辛烷-3-基2-苯乙酸酯 | (1R,3R,5S)-8-isopropyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylacetate | 88607-15-2 | 杂质对照品-异丙托溴铵 |
| 01-004 | Α-甲酰基苯乙酸8-(1-甲基乙基)-8-氮杂双环[3.2.1]辛酯 | (1R,3r,5S)-8-isopropyl-8-azabicyclo[3.2.1]octan-3-yl 3-oxo-2-phenylpropanoate | 22235-74-1 | 杂质对照品-异丙托溴铵 |
| 02-001 | 7-甲氧基-1-萘满酮 | 7-methoxy-3,4-dihydronaphthalen-1(2H)-one | 6836-19-7 | 杂质对照品-阿戈美拉汀 |
| 02-002 | 2-（7-甲氧基萘-1-基）乙酸 | 2-(7-methoxynaphthalen-1-yl)acetic acid | 6836-22-2 | 杂质对照品-阿戈美拉汀 |
| 02-003 | 7-甲氧基萘-1-醇 | 7-Methoxy-1-naphthol | 67247-13-6 | 杂质对照品-阿戈美拉汀 |
| 02-004 | （7-甲氧基-1-萘基）乙腈 | 2-(7-methoxynaphthalen-1-yl)acetonitrile | 138113-08-3 | 杂质对照品-阿戈美拉汀 |
| 02-005 | 2-（7-甲氧基-3,4-二氢-1-萘基）乙腈 | 2-(7-methoxy-3,4-dihydronaphthalen-1-yl)acetonitrile | 861960-34-1 | 杂质对照品-阿戈美拉汀 |
| 02-006 | 2-（7-甲氧基-1-萘基）乙腈 | 2-(7-methoxynaphthalen-1-yl)acetonitrile | 138113-08-3 | 杂质对照品-阿戈美拉汀 |
| 02-007 | 双（2-（1-（7-甲氧基萘乙基））胺 | bis(2-(7-methoxynaphthalen-1-yl)ethyl)amine | 1623104-92-6 | 杂质对照品-阿戈美拉汀 |
| 02-008 | 7-甲氧基-1-萘乙酰胺 | 2-(7-methoxynaphthalen-1-yl)acetamide | 138113-07-2 | 杂质对照品-阿戈美拉汀 |
| 02-009 | 1,3-双（2-(7-甲氧萘基-1-基）乙基）脲 | 1,3-bis(2-(7-methoxynaphthalen-1-yl)ethyl)urea | 185421-27-6 | 杂质对照品-阿戈美拉汀 |
| 02-010 | N,N-双[2-（7-甲氧基-1-萘基）乙基]-乙酰胺 | 2-(7-methoxynaphthalen-1-yl)ethyl acetate | 1385018-58-5 | 杂质对照品-阿戈美拉汀 |
| 02-011 | 2-（7-甲氧基-1-萘基）乙胺盐酸盐 | 2-(7-methoxynaphthalen-1-yl)ethan-1-amine hydrochloride | 139525-77-2 | 杂质对照品-阿戈美拉汀 |
| 03-001 | N-苯氧羰基哌嗪 | N-phenoxycarbonyl piperazine | 50606-33-2 | 杂质对照品-伏硫西汀 |
| 03-003 | 1-[(2-碘苯基)硫基]-2,4-二甲基苯 | (2,4-dimethylphenyl)(2-iodophenyl)sulfane | 1817707-37-1 | 杂质对照品-伏硫西汀 |
| 03-006 | (2-溴苯基)(3,5-二甲基苯基)硫烷 | (2-bromophenyl)(3,5-dimethylphenyl)sulfane | 1642185-28-1 | 杂质对照品-伏硫西汀 |
| 03-007 | (2-溴苯基)(2,6-二甲基苯基)硫烷 | (2-bromophenyl)(2,6-dimethylphenyl)sulfane | 1474022-91-7 | 杂质对照品-伏硫西汀 |
| 03-009 | 2-（（2,4-二甲基苯基）硫代）苯胺 | 2-((2,4-dimethylphenyl)thio)aniline | 1019453-85-0 | 杂质对照品-伏硫西汀 |
| 03-010 | 1-叔丁基- 4-苯基哌嗪-1,4-二甲酸酯 | 1-tert butyl 4-phenylpiperazin-1,4-dicarboxylic acid ester | 77278-74-1 | 杂质对照品-伏硫西汀 |
| 03-011 | 1-甲基-4-苯基哌嗪-1,4-二甲酸酯 | 1-methyl-4-phenylpiperazin-1,4-dicarboxylic acid ester | 1456059-86-1 | 杂质对照品-伏硫西汀 |
| 03-012 | 二苯基哌嗪-1,4-二甲酸酯 | Diphenylpiperazin-1,4-dicarboxylic acid ester | 3860-73-9 | 杂质对照品-伏硫西汀 |
| 03-013 | [1,1'-联二萘]-2,2'-二基双(二苯基氧化膦) | [1,1'-binaphthalene]-2,2'-diylbis(diphenylphosphine oxide) | 94041-18-6 | 杂质对照品-伏硫西汀 |
| 03-014 | 1-(2-溴苯基)- 4-(2-((2,4-二甲基苯基)硫烷基)苯基)哌嗪 | 1-(2-bromophenyl)-4-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine | 2425618-54-6 | 杂质对照品-伏硫西汀 |
| 03-015 | 1-(2-溴苯基)哌嗪 | 1- (2-bromophenyl) piperazine | 1011-13-8 | 杂质对照品-伏硫西汀 |
| 03-016 | 1,4-双(2-溴苯基)哌嗪 | 1,4-bis (2-bromophenyl) piperazine | 2243076-68-6 | 杂质对照品-伏硫西汀 |
| 03-017 | (2,4-二甲基苯基)(苯基)硫烷 | (2,4-dimethylphenyl) (phenyl) sulfide | 16704-47-5 | 杂质对照品-伏硫西汀 |
| 03-018 | 1-(3-((2,4-二甲基苯基)硫烷基)苯基)哌嗪 | 1- (3- (2,4-dimethylphenyl) thioalkyl) phenyl) piperazine | 2137588-68-0 | 杂质对照品-伏硫西汀 |
| 03-019 | 1-(4-((2,4-二甲基苯基)硫烷基)苯基)哌嗪 | 1- (4- (2,4-dimethylphenyl) thioalkyl) phenyl) piperazine | 1815608-51-5 | 杂质对照品-伏硫西汀 |
| 03-020 | 1-(2-((3,5-二甲基苯基)硫烷基)苯基)哌嗪 | 1- (2- (2,4-dimethylphenyl) thioalkyl) phenyl) piperazine | 508233-75-8 | 杂质对照品-伏硫西汀 |
| 03-021 | 1-(2-((2,6-二甲基苯基)硫烷基)苯基)哌嗪 | 1- (2- (2,6-dimethylphenyl) thioalkyl) phenyl) piperazine | 508233-76-9 | 杂质对照品-伏硫西汀 |
| 03-022 | 1-(2-((3,4-二甲基苯基)硫烷基)苯基)哌嗪 | 1- (2- (3,4-dimethylphenyl) thioalkyl) phenyl) piperazine | 1293489-74-3 | 杂质对照品-伏硫西汀 |
| 03-023 | 4- [2-(2,4-二甲基-苯硫基)-苯基]-哌嗪-1-醇 | 4- [2- (2,4-dimethyl-phenylthio) - phenyl] - piperazine-1-ol | 1393644-67-1 | 杂质对照品-伏硫西汀 |
| 03-024 | 1-(2-((2,4-二甲基苯基)亚磺酰基)苯基)哌嗪 | 1- (2- (2,4-dimethylphenyl) sulfinyl) phenyl) piperazine | 1429908-35-9 | 杂质对照品-伏硫西汀 |
| 03-025 | 1-(2-((2,4-二甲基苯基)磺酰基)苯基)哌嗪 | 1- (2- (2,4-dimethylphenyl) sulfonyl) phenyl) piperazine | 1639263-80-1 | 杂质对照品-伏硫西汀 |
| 03-026 | 1,2-双(4-(2-((2,4-二甲基苯基)硫烷基)苯基)哌嗪-1-基)乙基-1-酮 | 1,2-Bis (4- (2- ((2,4-dimethylphenyl) thioalkyl) phenyl) piperazin-1-yl) ethyl-1-one | 2476761-84-7 | 杂质对照品-伏硫西汀 |
| 04-001 | 2'-羟基-3'-氨基联苯-3-羧酸 | 2'-hydroxy-3'-amino-biphenyl-3-carboxylic acid | 376592-93-7 | 杂质对照品-艾曲泊帕乙醇胺 |
| 04-002 | 1-(3,4-二甲苯基)-3-甲基-1H-吡咯-5(4H)-酮 | 1-(3,4-dimethylphenyl)-3-methyl-1H-pyrazolin-5(4H)-one | 18048-64-1 | 杂质对照品-艾曲泊帕乙醇胺 |
| 04-004 | 艾曲泊帕 | eltrombopag | 496775-61-2 | 杂质对照品-艾曲泊帕乙醇胺 |
| 05-001 | 6α,9α-二氟-17α,11β-二羟基-16α-甲基-3-氧代雄甾-1,4-二烯-17β-甲酸 | 6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylic acid | 28416-82-2 | 杂质对照品-丙酸氟替卡松 |
| 05-002 | 6α,9α-二氟-11β-羟基-16α-甲基-3-氧代-17α-（1-氧代丙氧基）雄甾-1,4-二烯-17β-甲酸 | 6α, 9α-Difluoro-11β-Hydroxy-16α-methyl-3-oxo-17α-(1-oxopropyloxy) androstene-1,4-diene-17β-formic acid | 65429-42-7 | 杂质对照品-丙酸氟替卡松 |
| 05-003 | 17β-N,N-二甲基硫代氨基甲酰基-6α,9α-二氟-11β-羟基-16α-甲基-3-氧代-17α-（1-丙酸基）雄甾-1,4-二烯 | 17β-N,N-dimethylthioaminoformyl-6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-(1-propionyl)androstene-1,4-diene | 105638-31-1 | 杂质对照品-丙酸氟替卡松 |
| 05-004 | 6α,9α-二氟-11β-羟基-16α-甲基-3-氧代-17α-（1-氧代丙氧基）雄甾-1,4-二烯-17β-硫代甲酸 | 6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-(1-oxopropyloxy) androstene-1,4-diene-17β-thioformate | 80474-45-9 | 杂质对照品-丙酸氟替卡松 |
| 06-001 | 氟米松酸 | 6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylic acid | 28416-82-2 | 杂质对照品-糠酸氟替卡松 |
| 06-002 | 17-糠酸酯 | 6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxoandrosta-17α-（1-furancarboxylic）-1,4-diene-17β-methane acid | 397864-63-0 | 杂质对照品-糠酸氟替卡松 |
| 06-003 | 17-糠酸酯硫代羧酸 | 6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxoandrosta-17α-（1-1-furancarboxylic）-1,4-diene-17β-thiocarboxylic acid | 397864-40-3 | 杂质对照品-糠酸氟替卡松 |
| 07-004 | 11β,16α,17α,21-四羟基孕甾-1,4–二烯-3,20-二酮 | 11β,16α,17α,21-tetrahydroxyprogesterone-1,4-diene-3,20-dione | 13951-70-7 | 杂质对照品-布地奈德 |
| 08-001 | 5-(2R)-2-环氧乙烷基-8-苄氧基-2(1H)-喹啉酮 | 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone | 173140-90-4 | 杂质对照品-醋酸茚达特罗 |
| 08-003 | （R）-5-[2-（5，6-二乙基二氢茚-2-基氨基）-1-羟乙基]-8-羟基-1H-喹啉-2-酮 | (R) -5-[2- (5, 6-diethyldihydroindene-2-amino) -1-hydroxyethyl] -8-hydroxy-1H-quinolin-2-one | 312753-06-3 | 杂质对照品-醋酸茚达特罗 |
| 09-001 | 1-甲基-3-吡咯烷醇 | 1-Methyl-3-pyrrolidinol | 99445-21-3 | 杂质对照品-格隆溴铵 |
| 09-003 | α-环戊基扁桃酸甲酯 | methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate | 19833-96-6 | 杂质对照品-格隆溴铵 |
| 09-004 | 3-羟基-1，1-二甲基吡咯烷-1-溴化铵 | 3-hydroxy-1,1-dimethylpyrrolidin-1-ium, bromide | 51052-74-5 | 杂质对照品-格隆溴铵 |
| 09-005 | 1-甲基吡咯烷-3-基2-环戊基-2-羟基-2-苯乙酸酯 | 1-methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate | 13118-11-1 | 杂质对照品-格隆溴铵 |
| 09-006 | 2-亚环戊基-2-苯乙酸 | 2-cyclopentylidene-2-phenylacetic acid | 126497-27-6 | 杂质对照品-格隆溴铵 |
| 09-007 | 5-硝基间苯二甲酸 | 5-nitroisophthalic acid | 618-88-2 | 杂质对照品-格隆溴铵 |
| 09-008 | α-环戊基扁桃酸 | 2-cyclopentyl-2-hydroxy-2-phenylacetic acid | 427-49-6 | 杂质对照品-格隆溴铵 |
| 10-001 | 4-（嘧啶-2-基）哌嗪-1-羧酸叔丁酯 | Tert-butyl 4-pyrimidin-2-ylpiperazine-1-carboxylate | 780705-64-8 | 杂质对照品-枸橼酸坦度螺酮 |
| 10-002 | 2-哌嗪基嘧啶氢溴酸盐 | 2-Piperazinyl Pyrimidine, Hydrobromide（1：2） | 20980-22-7 | 杂质对照品-枸橼酸坦度螺酮 |
| 10-003 | 8-（2-嘧啶基）-8-氮杂-5-氮杂螺环[4.5]癸烷溴 | 8-(2-Pyrimidinyl)-8-aza-5-azoniaspiro[4.5]decane Bromide | 81461-73-6 | 杂质对照品-枸橼酸坦度螺酮 |
| 10-004 | （1S,2R,6S,7R）-4-[4-[4-（2-嘧啶基）哌嗪-1-基]丁基]-4-氮杂三环[5.2.1.02,6]癸烷-3,5-二酮（坦度螺酮） | (3aR,4S,7R,7aS)-2-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | 87760-53-0 | 杂质对照品-枸橼酸坦度螺酮 |
| 10-005 | (3AR,4S,7R,7AS)-2-(4-溴丁基)-4,7-亚甲基-1H-异吲哚-1,3(2H)-二酮 | (3aR,4S,7R,7aS)-2-(4-bromobutyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | 99095-09-7 | 杂质对照品-枸橼酸坦度螺酮 |
| 10-008 | 1,4-双-(2-嘧啶基)哌嗪 | 1,4-di(pyrimidin-2-yl)piperazine | 84746-24-7 | 杂质对照品-枸橼酸坦度螺酮 |
| 11-001 | 地索奈德 | Desonide/(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one | 638-94-8 | 杂质对照品-环索奈德 |
| 11-002 | 去甲丙酰基环索奈德 | (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one | 161115-59-9 | 杂质对照品-环索奈德 |
| 12-001 | 21-氯-9β,11β-环氧-17α-羟基-16α-甲基-1,4-孕甾二烯-3,20-二酮 | 21-Chloro-9β, 11β- Epoxy-17α-Hydroxy-16α- Methyl-1,4-gesteradien-3,20-dione | 83881-08-7 | 杂质对照品-糠酸莫米松 |
| 12-002 | 9β,11β-环氧-17α-羟基-16α-甲基-1,4-孕（甾）二烯-3,20-二酮-21-醋酸酯 | 9β, 11β - epoxy-17 α - hydroxy-16α - methyl-1,4-gesteradiene-3,20-dione-21-acetate | 2884-51-7 | 杂质对照品-糠酸莫米松 |
| 12-003 | 9β,11β-环氧-17α,21-二羟基-16α-甲基-1,4-孕（甾）二烯-3,2—二酮-21-对甲苯磺酸酯 | 9 β, 11β - epoxy-17α, 21-dihydroxy-16 α - methyl-1,4-gesteradiene-3,2-diketo-21-p-toluenesulfonate | 201601-32-3 | 杂质对照品-糠酸莫米松 |
| 12-004 | 9,21-二氯-11β,17-二羟基-16α-甲基-1,4-孕（甾）二烯-3,20-二酮 | 9,21-dichloro-11β, 17-dihydroxy-16α - methyl-1,4-gesteradiene-3,20-dione | 105102-22-5 | 杂质对照品-糠酸莫米松 |
| 12-005 | 21-氯-9β,11β-环氧-17α-羟基-16α-甲基-1,4-孕（甾）二烯-3,20-二酮-17-（2’-糠酸酯） | 21-chloro-9β, 11β - epoxy-17α - hydroxy-16α - methyl-1,4-gesteradiene-3,20-dione-17- (2 '- furoate) | 83881-09-8 | 杂质对照品-糠酸莫米松 |
| 12-009 | 9-氯-11β,17-二羟基-16α-甲基-3,20-二氧代孕甾-1,4-二烯-21-乙酸酯 | 9-Chloro-11β, 17-dihydroxy-16α - methyl-3,20-dioxyprogester-1,4-diene-21-acetate | 24916-91-4 | 杂质对照品-糠酸莫米松 |
| 12-010 | 9-氯-11β,17-二羟基-16α-甲基孕甾-1,4-二烯-3,20-二酮 | 9-Chloro-11β, 17-dihydroxy-16α - methylpregnester-1,4-diene-3,20-dione | 57780-86-6 | 杂质对照品-糠酸莫米松 |
| 12-011 | 9-氯-11β,17,21-三羟基-16α-甲基孕甾-1,4-二烯-3,20-二酮 | 9-chloro-11β, 17,21-trihydroxy-16α - methylpregnester-1,4-diene-3,20-dione | 4647-20-5 | 杂质对照品-糠酸莫米松 |
| 13-001 | 氧苄基苯甲酸甲酯席夫碱 | methyl (E)-2-(benzyloxy)-5-(2-(tert-butylimino)acetyl)benzoate | 345322-10-3 | 杂质对照品-硫酸沙丁胺醇 |
| 13-002 | 氧苄基沙丁胺醇甲酸甲酯 | methyl 2-(benzyloxy)-5-(2-(tert-butylamino)-1-hydroxyethyl)benzoate | 174607-70-6 | 杂质对照品-硫酸沙丁胺醇 |
| 13-003 | 氧苄基沙丁胺醇 | 1-(4-(benzyloxy)-3-(hydroxymethyl)phenyl)-2-(tert-butylamino)ethan-1-ol | 56796-66-8 | 杂质对照品-硫酸沙丁胺醇 |
| 13-004 | 5-乙酰水杨酸甲酯 | Methyl 5-acetylsalicylate | 16475-90-4 | 杂质对照品-硫酸沙丁胺醇 |
| 13-005 | 氧苄基乙酰苯甲酸甲酯 | Methyl 2-(benzyloxy)-5-acetylbenzoate | 27475-09-8 | 杂质对照品-硫酸沙丁胺醇 |
| 13-006 | 4-(苄氧基)-3-(甲氧羰基)苯甲酸 | 4-(benzyloxy)-3-(methoxycarbonyl)benzoic acid | 1285516-45-1 | 杂质对照品-硫酸沙丁胺醇 |
| 13-008 | 5-(2-(叔丁基氨基)-1-羟乙基)-2-羟基苯甲酸甲酯 | methyl 5-(2-(tert-butylamino)-1-hydroxyethyl)-2-hydroxybenzoate | 27566-09-2 | 杂质对照品-硫酸沙丁胺醇 |
| 13-011 | 4-[2-(叔丁基氨基)-1-甲氧基乙基]-2-(羟甲基)苯酚 | 4-[(1RS)-2-(tert-butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol, | 870076-72-5 | 杂质对照品-硫酸沙丁胺醇 |
| 14-001 | 氧苄基沙丁胺醇甲酸甲酯 | 2-Benzyloxy-5- [2- (tert butylamino) -1-hydroxyethyl] benzoate methyl ester | 174607-70-6 | 杂质对照品-盐酸左沙丁胺醇 |
| 14-004 | 左旋氧苄基沙丁胺醇 | (R) -1- (4- (benzyloxy) -3- (hydroxymethyl) phenyl) -2- (tert butylamino) ethyl-1-ol | 174607-68-2 | 杂质对照品-盐酸左沙丁胺醇 |
| 15-001 | (E)-5-甲氧基-1-[4-(三氟甲基)苯基]-1-戊酮肟 | (E)-5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one oxime | 61747-22-6 | 杂质对照品-马来酸氟伏沙明 |
| 15-002 | 5-甲氧基-1-(4-三氟甲基)戊酮 | 5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one | 61718-80-7 | 杂质对照品-马来酸氟伏沙明 |
| 15-003 | 2-氯乙胺盐酸盐 | 2-Chloroethylaminehydrochloride | 870-24-6 | 杂质对照品-马来酸氟伏沙明 |
| 15-004 | (2Z,9E)-4-氧代-10-[4-(三氟甲基)苯基]-8,15-二氧杂-5,9-二氮杂十六烷-2,9-二烯酸 | (7E,14Z)-13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid | 1076198-14-5 | 杂质对照品-马来酸氟伏沙明 |
| 16-002 | 氯化（3α-去甲托品醇）-8-螺-1’-吡咯 | (1R,3r,5S)-3-hydroxyspiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-8-ium chloride | 3464-71-9 | 杂质对照品-曲司氯铵 |
| 16-003 | 3-羟基-去甲托烷-8-甲酸乙酯 | ethyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate | 30833-12-6 | 杂质对照品-曲司氯铵 |
| 16-004 | (1R,3r,5S)-8-氮杂双环[3.2.1] 辛烷-3-基羟基二苯乙酸酯 | (1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate | 63516-30-3 | 杂质对照品-曲司氯铵 |
| 16-005 | 2-羟基-2,2-二苯乙酸异丙酯 | isopropyl 2-hydroxy-2,2-diphenylacetate | 4055/6/5 | 杂质对照品-曲司氯铵 |
| 17-001 | 2,2-二噻吩基乙醇酸甲酯 | Methyl 2-hydroxy-2,2-dithiophen-2-yl acetate | 26447-85-8 | 杂质对照品-噻托溴铵 |
| 17-002 | 2,2-二噻吩基乙醇酸东莨菪酯 | Scopine-2,2-dithienyl glycolate | 136310-64-0 | 杂质对照品-噻托溴铵 |
| 17-003 | 异东莨菪醇 | Scopoline | 487-27-4 | 杂质对照品-噻托溴铵 |
| 17-004 | 2-羟基-2,2-二噻吩基乙酸 | hydroxy[di(thiophen-2-yl)]acetic acid | 4746-63-8 | 杂质对照品-噻托溴铵 |
| 17-005 | 2-羟基-2,2-二噻吩基乙酰噻吩 | 2-hydroxy-1,2,2-tri(thiophen-2-yl)ethanone | 2512209-13-9 | 杂质对照品-噻托溴铵 |
| 17-006 | (1R,2R,4S,5S,,7s)-7-羟基-9,9-二甲基-3-环氧-9-氮阳离子三环[3.3.1.02,4]壬烷溴化物 | (1R,2R,4S,5S,7s)-7-hydroxy-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide | 1508-46-9 | 杂质对照品-噻托溴铵 |
| 17-007 | (1s,3RS,4RS,5RS,7SR)-4-羟基-6,6-二甲基-2-环氧-6-氮阳离子三环[3.3.1.03,7]壬烷溴化物 | (1s,3RS,4RS,5RS,7SR)-4-hydroxy-6,6-dimethyl-2-oxa-6-azatricyclo[3.3.1.03,7]nonan-6-ium bromide | 845870-40-8 | 杂质对照品-噻托溴铵 |
| 18-001 | (R)-2-((6-(2-((2,6-二氯苄基)氧基)乙氧基)己基)氨基)-1-(2,2-二甲基-4H-苯并[d][1,3]二噁英-6-基)乙烷-1-醇丁二酸盐 | (R)-2-((6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)ethan-1-ol succinate | 2522953-10-0 | 杂质对照品-三苯乙酸维兰特罗 |
| 19-001 | 2-(羟甲基)-4-[1-羟基-2-[6-(4-苯基丁氧)己基氨基]乙基]-苯酚（沙美特罗） | 4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol | 89365-50-4 | 杂质对照品-昔萘酸沙美特罗 |
| 20-001 | 二苯基（奎宁环-4-基）甲醇 | diphenyl(quinuclidin-4-yl)methanol | 461648-39-5 | 杂质对照品-乌美溴铵 |
| 20-002 | 奎宁环-4-甲酸乙酯 | ethyl quinuclidine-4-carboxylate | 22766-68-3 | 杂质对照品-乌美溴铵 |
| 20-003 | 苄基-2-溴乙基醚 | ((2-bromoethoxy)methyl)benzene | 1462-37-9 | 杂质对照品-乌美溴铵 |
| 21-001 | [1- [2-氧代-2 - [[4- [4-（嘧啶-2-基）哌嗪-1-基]丁基]氨基]乙基]环戊基]乙酸（EP杂质E） | [1-[2-Oxo-2-[[4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl]amino]ethyl] cyclopentyl]acetic acid | 257877-46-6 | 杂质对照品-盐酸丁螺环酮 |
| 21-002 | 8-（4-（4-（5-氯嘧啶-2-基）哌嗪-1-基）丁基）-8-氮杂螺[4.5]癸-7,9-二酮（EP杂质I） | 8-[4-[4-(5-chloro-2-pyrimidinyl)-1-piperazinyl]butyl]-8-Azaspiro[4.5]decane-7,9-dione | 2725354-99-2 | 杂质对照品-盐酸丁螺环酮 |
| 21-003 | 3,3-四亚甲基戊二酰亚胺（EP杂质K） | 3,3-Tetramethyleneglutarimide | 1075-89-4 | 杂质对照品-盐酸丁螺环酮 |
| 22-001 | 2-(4-氨基苯基)丁酸 | 2-(4-aminophenyl)butanoic acid | 29644-97-1 | 杂质对照品-吲哚布芬 |
| 22-002 | 2-(4-硝基苯基)丁酸 | 2-(4-nitrophenyl)butanoic acid | 7463-53-8 | 杂质对照品-吲哚布芬 |
| 22-003 | 2-甲酰基苯甲酸 | 2-formylbenzoic acid | 119-67-5 | 杂质对照品-吲哚布芬 |
| 22-004 | 2-(4-乙酰氨基苯基)丁酸 | 2-(4-acetamidophenyl)butanoic acid | 858847-40-2 | 杂质对照品-吲哚布芬 |
| 22-006 | 2-(4-(1,3-二氧代异吲哚啉-2-基)苯基)丁酸 | 2-(4-(1,3-dioxoisoindolin-2-yl)phenyl)butanoic acid | 94232-67-4 | 杂质对照品-吲哚布芬 |
| 22-007 | 2-(((4-(1-羧丙基)苯基)氨基)甲基)苯甲酸 | 2-(((4-(1-carboxypropyl)phenyl)amino)methyl)benzoic acid | 203313-55-7 | 杂质对照品-吲哚布芬 |
| 22-008 | 2-(4-(1-氧代异吲哚-2-基)苯基)丁酸乙酯 | ethyl 2-(4-(1-oxoisoindolin-2-yl)phenyl)butanoate | 36691-02-8 | 杂质对照品-吲哚布芬 |
| 22-009 | 2-(4-(1-氧代异吲哚-2-基)苯基)丁酸甲酯 | methyl 2-(4-(1-oxoisoindolin-2-yl)phenyl)butanoate | 2244443-94-3 | 杂质对照品-吲哚布芬 |
| 23-001 | (R)-N-(1-苯基乙基) 甲基磺酰胺 | (R)-N-(1-phenylethyl)methanesulfonamide | 316363-65-2 | 杂质对照品-盐酸鲁拉西酮 |
| 23-002 | (1S,2S)-1,2-环己烷二甲醇二甲磺酸酯 | (1S,2S)-cyclohexane-1,2-dimethanol bis(methanesulfonate) | 173658-50-9 | 杂质对照品-盐酸鲁拉西酮 |
| 23-003 | 顺-1,2-环己烷二甲醇二甲磺酸酯 | 1,2-cis-bis(methanesulfonyloxymethyl)cyclohexane | 66347-68-0 | 杂质对照品-盐酸鲁拉西酮 |
| 23-004 | 鲁拉西酮亚砜 | (3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(1-Oxidobenzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | 1809325-45-8 | 杂质对照品-盐酸鲁拉西酮 |
| 23-005 | 鲁拉西酮砜 | 2-((2-((4-(1,1-Dioxidobenzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | 1644295-09-9 | 杂质对照品-盐酸鲁拉西酮 |
| 24-001 | 2-氯-N-(2-氯乙基)-N-甲基-2-苯基乙烷-1-胺盐酸盐 | 2-chloro-N-(2-chloroethyl)-N-methyl-2-phenylethan-1-amine hydrochloride | 6407-19-8 | 杂质对照品-盐酸米安色林 |
| 24-004 | (14bRS)-1,2,3,4,10,14b-六氢二苯并-[c,f]吡嗪并[1,2-a]氮杂平 | (14bRS)-1,2,3,4,10,14b-hexahydrodibenzo- | 71936-92-0 | 杂质对照品-盐酸米安色林 |
| [c,f]pyrazino[1,2-a]azepine | ||||
| 24-005 | (14bRS)-2-甲基-1,2,3,4,10,14b-六氢二苯并-[c,f]吡嗪并[1,2-a]氮杂平 | 2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine | 24219-97-4 | 杂质对照品-盐酸米安色林 |
| 25-001 | （1-（2-甲胺基）乙基）哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 743460-48-2 | 杂质对照品-雷芬那辛 |
| 25-002 | 1-（2-（4-甲酰基-N-甲基苯甲酰胺）乙基）哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 864760-28-1 | 杂质对照品-雷芬那辛 |
| 25-004 | 哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 171722-92-2 | 杂质对照品-雷芬那辛 |
| 25-005 | N-苄基-2-氯-N-甲基乙胺 | N-benzyl-2-chloro-N-methyl-ethanamine | 17542-47-1 | 杂质对照品-雷芬那辛 |
| 25-006 | 1-苄基哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 171723-80-1 | 杂质对照品-雷芬那辛 |
| 25-008 | 对苯二甲酸 | Terephthalic acid | 100-21-0 | 杂质对照品-雷芬那辛 |
| 25-009 | 苯甲酸 | Benzoic acid | 65-85-0 | 杂质对照品-雷芬那辛 |
| 25-013 | 1-(2-氨基乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(2-aminoethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 743460-61-9 | 杂质对照品-雷芬那辛 |
| 25-015 | 4-(4,6-二甲氧基三嗪-2-基)-4-甲基吗啉盐酸盐(DMTMM) | 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium chloride | 3945-69-5 | 杂质对照品-雷芬那辛 |
| 25-019 | 1-（2-（4-（羟甲基）-N-甲基苯甲酰）乙基）哌啶-4-基[1，1'-联苯]-2-基氨基甲酸酯 | 1-(2-(4-(hydroxymethyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 1682660-39-4 | 杂质对照品-雷芬那辛 |
| 25-020 | 1-（4-（2-（4-（（[1，1'-联苯]-2-基氨甲酰）氧基）哌啶-1-基）乙基）（甲基）氨甲酰）苄基）哌啶-4-羧酸 | 1-(4-((2-(4-(([1,1'-biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)piperidine-4-carboxylic acid | 909800-36-8 | 杂质对照品-雷芬那辛 |
| 26-001 | 4-（3-氟苄氧基）苯甲醛 | 4-(3-fluoro-benzyloxy)-benzaldehyde | 66742-57-2 | 杂质对照品-甲磺酸沙芬酰胺 |
| 27-002 | N,N-二乙基对甲苯磺酰胺 | N,N-diethyl-4-methylbenzenesulfonamide | 649-15-0 | 杂质对照品-盐酸卡利拉嗪 |
| 27-004 | （（1r，4r）-4-（2-（4-（2,3-二氯苯基）哌嗪-1-基）乙基）环己基）氨基甲酸甲酯 | trans N-(4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-cyclohexyl)carbamic acid methylester | 1231947-89-9 | 杂质对照品-盐酸卡利拉嗪 |
| 28-001 | 对氯苄基异硫脲盐酸盐 | 2-(4-chlorobenzyl)isothiouronium chloride | 544-47-8 | 杂质对照品-硝酸硫康唑 |
| 28-003 | 硫康唑 | Sulconazole | 61318-90-9 | 杂质对照品-硝酸硫康唑 |
| 28-004 | 2-氯苄基异硫脲盐酸盐 | 2-(2-chlorobenzyl)isothiouronium chloride | 3778-85-6 | 杂质对照品-硝酸硫康唑 |
| 28-005 | 3-氯苄基异硫脲盐酸盐 | 2-(3-chlorobenzyl)isothiouronium chloride | 133067-71-7 | 杂质对照品-硝酸硫康唑 |
| 28-006 | 1-[2-(2-氯苄硫基)-2-(2,4-二氯苯基)乙基]-1H-咪唑 | 1-[2-(2-Chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole | 3778-85-6 | 杂质对照品-硝酸硫康唑 |
| 29-004 | 福莫特罗 | Formoterol | 73573-87-2 | 杂质对照品-富马酸福莫特罗 |
| 30-001 | (R)-N-(2-(苄氧基)-5-(2-溴-1-羟基乙基)苯基)甲酰胺 | (R)-N-(2-(benzyloxy)-5-(2-bromo-1-hydroxyethyl)phenyl) formamide | 201677-59-0 | 杂质对照品-酒石酸阿福特罗 |
| 30-002 | (R)-N-苄基-1-(4-甲氧基苯基)丙-2-胺-（S）-扁桃酸盐 | (R)-N-benzyl-1-(4-methoxyphenyl) propane-2-amine-(S)-mandelic acid salt | 188690-84-8 | 杂质对照品-酒石酸阿福特罗 |
| 31-001 | 2，6-二氨基-4-氯嘧啶-1-氧化物 | 2,6-diamino-4-chloropyrimidine 1-oxide | 35139-67-4 | 杂质对照品-米诺地尔 |
| 31-002 | 2,4-二氨基-5,6-二氯嘧啶 | 5,6-dichloropyrimidine-2,4-diamine | 89033-89-6 | 杂质对照品-米诺地尔 |
| 31-003 | 2,4-二氨基-6-甲氧基嘧啶 | 6-methoxypyrimidine-2,4-diamine | 3270-97-1 | 杂质对照品-米诺地尔 |
| 31-004 | 6-氨基-4-氯-2-（氯氨基）嘧啶-1-氧化物 | 2,6-diamino-4,5-dichloropyrimidine-1-oxide | 35139-68-5 | 杂质对照品-米诺地尔 |
| 31-005 | 2,6-二氨基-4,5-二氯嘧啶1-氧化物 | 2,6-diamino-5-chloro-4-(piperidin-1-yl)pyrimidine-1-oxide | 2889432-05-5 | 杂质对照品-米诺地尔 |
| 33-002 | 苯并异噁唑盐酸盐 | 6-fluoro-3-(piperidin-4-yl)benzo[d]isoxazole | 84163-13-3 | 杂质对照品-帕利哌酮 |
| 33-004 | 帕潘立酮 | (±)-3-2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one | 144598-75-4 | 杂质对照品-帕利哌酮 |
可提供、定制多种原料药杂质对照品：
| 产品编号/货号 | 产品中文名称 | 产品英文名称 | 产品关键词 |
| 03-002 | 1-[2-(2,4-二甲基-苯硫基)-苯基]-哌嗪，氢溴酸盐，异丙醇合物 | Vothixetine hydrobromide isopropanol compound | 杂质对照品；伏硫西汀 |
| 03-004 | (3-溴苯基)(2,4-二甲基苯基)硫烷 | (3-bromophenyl)(2,4-dimethylphenyl)sulfane | 杂质对照品；伏硫西汀 |
| 03-005 | (4-溴苯基)(2,4-二甲基苯基)硫烷 | (4-bromophenyl)(2,4-dimethylphenyl)sulfane | 杂质对照品；伏硫西汀 |
| 03-008 | (2-溴苯基)(3,4-二甲基苯基)硫烷 | (2-bromophenyl)(3,4-dimethylphenyl)sulfane | 杂质对照品；伏硫西汀 |
| 04-003 | E异构体 | 3'-((2E)-2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazineyl)-2'-hydroxy-3-carboxylic acid | 杂质对照品；艾曲泊帕乙醇胺 |
| 07-001 | 21-羟基孕甾-1,4,9(11) ,16-四烯-3,20-二酮-21-醋酸酯 | 21-hydroxyprogesterone-1,4,9 (11), 16-tetraene-3,20-dione-21-acetate | 杂质对照品；布地奈德 |
| 07-002 | 9α-溴-11β,16α,17α-三羟孕甾-1,4-二烯-3,20-二酮-21-醋酸酯 | 9α-bromine-11β,16α,17α-trihydroxyprogesterone-1,4-diene-3,20-dione-21-acetate | 杂质对照品；布地奈德 |
| 07-003 | 11,16,17,21-四羟孕甾-1,4-二烯-3,20-二酮-21-醋酸酯 | 11,16,17,21-tetrahydroxyprogesterone-1,4-diene-3,20-dione-21-acetate | 杂质对照品；布地奈德 |
| 08-002 | （R）-5-[2-（5，6-二乙基二氢茚-2-基氨基）-1-羟乙基]-8-苄氧基-1H-喹啉-2-酮苯甲酸盐 | (R) -5-[2- (5, 6-diethyldihydroindene-2-amino) -1-hydroxyethyl] -8-benzoxy-1H-quinolin-2-keto benzoate | 杂质对照品；醋酸茚达特罗 |
| 09-002 | 1-甲基吡咯烷-3-基-2-环戊基-2-羟基-2-苯乙酸酯 5-硝基间苯二甲酸盐（GP-5NA） | 1-methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate 5-nitroisophthalate | 杂质对照品；格隆溴铵 |
| 10-006 | (3AR, 3A'R,4S, 4'S,7R,7AS,7'R, 7a'S)-2-2'-)丁烷-1,4-二基)双)- 4,7-亚甲基-1H-异吲哚-1,3(2H)-二酮) | (3aR,3a'R,4S,4'S,7R,7aS,7'R,7a'S)-2,2'-(butane-1,4-diyl)bis(hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione) | |
| 10-007 | (3AR,4S,7R,7AS) -2-丁基-4,7-亚甲基-1H-异吲哚-1,3(2H)-二酮 | (3aR,4S,7R,7aS)-2-butylhexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | 杂质对照品；枸橼酸坦度螺酮 |
| 12-006 | 9-氯-11β,17-二羟基-16α-甲基-3,20-二氧代孕甾-1,4-二烯-21-对甲苯磺酸酯 | 9-Chloro-11β, 17-dihydroxy-16α - methyl-3,20-dioxyprogester-1,4-diene-21-p-toluenesulfonic acid ester | 杂质对照品；糠酸莫米松 |
| 12-007 | 9-氯-11β-羟基-16α-甲基-21-[(对甲苯磺酰)基]-3,20-二氧代孕甾-1,4-二烯-17-(2-糠酸酯) | 9-chloro-11β - hydroxy-16α - methyl-21- [(p-toluenesulfonyl)] -3,20-dioxyprogester-1,4-diene-17- (2-furoate) | 杂质对照品；糠酸莫米松 |
| 12-008 | 9-氯-11β,17-二羟基-16α-甲基-3,20-二氧代孕甾-1,4-二烯-21-(2-糠酸酯) | 9-Chloro-11β, 17-dihydroxy-16α - methyl-3,20-dioxyprogester-1,4-diene-21- (2-furoate) | 杂质对照品；糠酸莫米松 |
| 13-007 | 2-(苄氧基)-3-(2-(叔丁基氨基)-1-羟乙基)苯甲酸甲酯 | methyl 2-(benzyloxy)-3-(2-(tert-butylamino)-1-hydroxyethyl)benzoate | 杂质对照品；硫酸沙丁胺醇 |
| 13-009 | 2-(苄氧基)-5-(1,2-二羟乙基)苯甲酸甲酯 | methyl 2-(benzyloxy)-5-(1,2-dihydroxyethyl)benzoate | 杂质对照品；硫酸沙丁胺醇 |
| 13-010 | 2-(苄氧基)-5-(2-(叔丁基氨基)-1-羟乙基)苯甲酸 | 2-(benzyloxy)-5-(2-(tert-butylamino)-1-hydroxyethyl)benzoic acid | 杂质对照品；硫酸沙丁胺醇 |
| 14-002 | 左旋氧苄基沙丁胺甲酸甲酯DBTA盐 | (R) -2- (benzyloxy) -5- (2- (tert butylamino) -1-hydroxyethyl) benzoate methyl ester semi (2,3-bis (benzoyloxy) succinate) | 杂质对照品；盐酸左沙丁胺醇 |
| 14-003 | 左旋氧苄基沙丁胺甲酸甲酯 | (R) -2- (benzyloxy) -5- (2- (tert butylamino) -1-hydroxyethyl) benzoate methyl ester | 杂质对照品；盐酸左沙丁胺醇 |
| 21-004 | 2-(1-(2-氧-2-((4-(4-(嘧啶-2-基)哌嗪-1-基)丁基)氨基)乙基)环戊基)乙酸丁酯 | 2- (1- (2-Oxy-2- (4- (4- (pyrimidin-2-yl) piperazin-1-yl) butyl) amino) ethyl) cyclopentyl) butyl acetate | 杂质对照品；盐酸丁螺环酮 |
| 21-005 | 2-(1-(2-氧代-2-((4-(4-(嘧啶-2-基)哌嗪-1-基)丁基)氨基)乙基)环戊基)乙酸乙酯 | 2- (1- (2-oxo-2- (4- (4- (pyrimidin-2-yl) piperazin-1-yl) butyl) amino) ethyl) cyclopentyl) ethyl acetate | 杂质对照品；盐酸丁螺环酮 |
| 22-005 | 2-(4-甲酰氨基苯基)丁酸 | 2-(4-formamidophenyl)butanoic acid | 杂质对照品；吲哚布芬 |
| 22-010 | 2,2′-((4-(1-羧丙基)苯基)氮杂二酰基)二(亚甲基)二苯甲酸 | 2,2'-(((4-(1-carboxypropyl)phenyl)azanediyl)bis(methylene))dibenzoic acid | 杂质对照品；吲哚布芬 |
| 24-002 | (2-(4-甲基-2-苯基哌嗪-1-基)苯基)甲醇盐酸盐 | (2-(4-methyl-2-phenylpiperazin-1-yl)phenyl)methanol hydrochloride | 杂质对照品；盐酸米安色林 |
| 24-003 | (2-(2-苯基哌嗪-1-基)苯基)甲醇 | (2-(2-phenylpiperazin-1-yl)phenyl)methanol | 杂质对照品；盐酸米安色林 |
| 25-007 | 1-(2-(N-甲基甲酰胺基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(2-(N-methylformamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 杂质对照品；雷芬那辛 |
| 25-010 | 1-(2-(乙基(甲基)氨基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(2-(ethyl(methyl)amino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 杂质对照品；雷芬那辛 |
| 25-011 | 1-(2-(异丙基(甲基)氨基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(2-(isopropyl(methyl)amino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 杂质对照品；雷芬那辛 |
| 25-012 | 1-(2-(二甲氨基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(2-(dimethylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 杂质对照品；雷芬那辛 |
| 25-014 | 1-(2-((4,6-二甲氧基-1,3,5-三嗪-2-基)(甲基)氨基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(2-((4,6-dimethoxy-1,3,5-triazin-2-yl)(methyl)amino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 杂质对照品；雷芬那辛 |
| 25-016 | 1-(4-甲酰基苯甲酰基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(4-formylbenzoyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 杂质对照品；雷芬那辛 |
| 25-017 | 1-(4,6-二甲氧基-1,3,5-三嗪-2-基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 1-(4,6-dimethoxy-1,3,5-triazin-2-yl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 杂质对照品；雷芬那辛 |
| 25-018 | 1-（2-（N，4-二甲基苯甲酰胺基）乙基）哌啶-4-基[1，1'-联苯]-2-基氨基甲酸酯 | 1-(2-(N,4-dimethylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 杂质对照品；雷芬那辛 |
| 27-001 | 反式-2-(4-氨基环己基)对甲苯磺酸乙酯 | Trans-2- (4-aminocyclohexyl) p-toluenesulfonic acid ethyl ester | 杂质对照品；盐酸卡利拉嗪 |
| 27-003 | 4-(2，3-二氯苯基)-1-(2-((1r，4r)-4-(3，3-二甲基脲基)环己基)乙基)哌嗪1-氧化物 | 4- (2,3-dichlorophenyl) -1- (2- (((1r, 4r) -4- (3,3-dimethylurea) cyclohexyl) ethyl) piperazine 1-oxide | 杂质对照品；盐酸卡利拉嗪 |
| 28-002 | 氯代咪唑乙醇硫酸盐 | 1-(2-chloro-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole sulfate | 杂质对照品；硝酸硫康唑 |
| 28-007 | 1-[2-(3-氯苄硫基)-2-(2,4-二氯苯基)乙基]-1H-咪唑 | 1-[2-(3-Chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole | 杂质对照品；硝酸硫康唑 |
| 29-001 | 4-苄氧基-3-硝基苯基环氧乙烷 | 4-benzyloxy-3-nitrophenylepoxyethane | 杂质对照品；富马酸福莫特罗 |
| 29-002 | 4-苄氧基-3-氨基-α-[ N-苄基- N-（1-甲基-2-对甲氧基苯基乙基）氨基甲基]苄醇 | 4-benzyloxy-3-amino-α-[N-benzyl-N-(1-methyl-2-p-methoxyphenylethyl) amino methyl] benzyl alcohol | 杂质对照品；富马酸福莫特罗 |
| 29-003 | 4-苄氧基-3-甲酰氨基-α-[ N-苄基- N-（1-甲基-2-对甲氧基苯基乙基）氨基甲基]苄醇富马酸盐 | 4-benzyloxy-3-formylamino-α-[N-benzyl-N-(1-methyl-2-p-methoxyphenylethyl) amino methyl] benzyl alcohol fumarate salt | 杂质对照品；富马酸福莫特罗 |
| 32-001 | 去甲奈诺沙星 | (S)-7-(3-aminopiperidin-1-yl)-1-cyclopropyl-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 杂质对照品；苹果酸奈诺沙星 |
| 33-001 | [(Z)-(2,4-二氟苯基)(六氢吡啶-4-基)甲亚基]羟胺盐酸盐 | (Z)-(2,4-difluorophenyl)(piperidin-4-yl)methanone oxime | 杂质对照品；帕利哌酮 |
| 33-003 | 3-(2-{4-[(2,4-二氟苯基)羰基]六氢吡啶-1-基}乙基)-9-羟基-2-甲基-6,7,8,9-四氢-4H-吡啶并[1,2-a]嘧啶-4-酮 | 3-(2-(4-(2,4-difluorobenzoyl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one | 杂质对照品；帕利哌酮 |
| 项目名称 | 杂质中文名称 | 杂质英文名称 | CAS号 | 货号 |
| 左西孟旦杂质 | (S)-N-(4-(4-甲基-6-氧代-1,4,5,6-四氢哒嗪-3-基)苯基)羰基亚肼基丙二腈 | (S)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)carbonohydrazonoyl dicyanide | 144238-75-5 | 34-001 |
| 左西孟旦杂质 | (R)-2-氨基-N-(4-(4-甲基-6-氧代-1,4,5,6-四氢哒嗪-3-基)苯基)-2-氧代乙酰肼基氰化物 | (R,E)-2-amino-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-2-oxoacetohydrazonoyl cyanide | 274263-65-9 | 34-002 |
| 左西孟旦杂质 | (R)-N-(4-(4-甲基-6-氧代-1,4,5,6-四氢哒嗪-3-基)苯基)羰基亚肼基丙二酰胺 | (R)-2-(2-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)hydrazineylidene)malonamide | N/A | 34-003 |
| 左西孟旦杂质 | (E)-3-(氰基((E)-(4-((R)-4-甲基-6-氧代-1,4,5,6-四氢哒嗪-3-基)苯基)二氮烯基)亚甲基)-5-亚氨基-2-(4-(R)4-甲基-6-氧基-1,4,5,5-四氢哒肼-3-基)苯基)-2,3,4,5-四氢-1,2,4-三嗪-6-腈 | (E)-3-(cyano((E)-(4-((R)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)diazenyl)methylene)-5-imino-2-(4-((R)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile | N/A | 34-004 |
| 非奈利酮杂质 | 4-（4-氰基-2-甲氧基苯基）-5-乙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-羧酸乙酯 | 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, ethyl ester, | N/A | 35-001 |
| 非奈利酮杂质 | 4-（4-氰基-2-甲氧基苯基）-5-乙氧基-2,8-二甲基-1,6-萘啶-3-酰胺 | 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine-3-carboxamide | 2084136-51-4 | 35-002 |
| 非奈利酮杂质 | 2-氰基乙基-4-(4-氰基-2-甲氧苯基)-2,8-二甲基-5-异丙氧基-1,4-二氢-1,6-萘啶-3-羧酸酯 | 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-isopropoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate | N/A | 35-003 |
| 非奈利酮杂质 | 2-氰基乙基-4-（4-氰基-2-甲氧基苯基）-5-甲氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-羧酸酯 | 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-methoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate | N/A | 35-004 |
| 非奈利酮杂质 | 4-（4-氰基-2-甲氧基苯基）-5-异丙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-羧酸 | 4-(4-cyano-2-methoxyphenyl)-5-isopropoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid | 2640280-87-9 | 35-005 |
| 非奈利酮杂质 | 4-（4-氰基-2-甲氧基苯基）-5-甲氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-羧酸 | 4-(4-cyano-2-methoxyphenyl)-5-methoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid | 2640280-86-8 | 35-006 |
| 非奈利酮杂质 | 2-氰基乙基-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-2,8-二甲基-1,6-萘啶-3-羧酸酯 | 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine-3-carboxylate | 2924224-42-8 | 35-007 |
| 非奈利酮杂质 | 4-（4-氰基-2-甲氧基苯基）-5-异丙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-酰胺 | 4-(4-cyano-2-methoxyphenyl)-5-isopropoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide | 2640280-85-7 | 35-008 |
| 非奈利酮杂质 | 4-（4-氰基-2-甲氧基苯基）-5-乙氧基-2,8-二甲基-1,6-萘啶-3-羧酸 | 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine-3-carboxylic acid | N/A | 35-009 |
| 非奈利酮杂质 | 4-（4-氰基-2-甲氧基苯基）-5-甲氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-酰胺 | 4-(4-cyano-2-methoxyphenyl)-5-methoxy-2,8-dimethyl-1,4-dihydro- 1,6-naphthyridine-3-carboxamide | 2640280-84-6 | 35-010 |
| 非奈利酮杂质 | 2-氰基乙基 4-（4-氰基-2-甲氧基苯基）-2,8-二甲基-5-氧代-5,6-二氢-1,6-萘啶-3-羧酸酯 | 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-5,6-dihydro-1,6-naphthyridine-3-carboxylate | N/A | 35-011 |
| 非奈利酮杂质 | 4-(5-乙氧基-3-(1H-咪唑-1-羰基)-2,8-二甲基-1,4-二氢-1,6-萘啶-4-基)-3-甲氧基苯腈 | 4-(5-ethoxy-3-(1H-imidazole-1-carbonyl)-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-4-yl)-3-methoxybenzonitrile | 1050477-58-1 | 35-012 |
| 非奈利酮杂质 | (R)-4-(4-氰基-2-甲氧苯基)-5-乙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-甲酰胺 | (R)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide | 1050477-30-9 | 35-013 |
可转让现有进度项目，可申报或获批后转让。项目经验丰富，研究内容充分，可保证数据可靠性。本公司都有相应生产线，可受托加工。可现有进度转让，可接受委托CDMO/CMO。转让项目列表如下：
| 项目名称 | 化药注册分类 | 适应症 |
| 酒石酸阿福特罗雾化吸入溶液 | 3 | COPD |
| 丙酸氟替卡松雾化吸入用混悬液 | 4 | 哮喘 |
| 利多卡因丙胺卡因气雾剂 | 3 | 早泄 |
| 丙酸氟替卡松鼻喷剂 | 4 | 过敏性鼻炎 |
| 盐酸氮䓬斯汀鼻喷雾剂 | 4 | 过敏性鼻炎 |
| 糠酸氟替卡松鼻用喷雾剂 | 4 | 过敏性鼻炎 |
| 布地奈德鼻喷雾剂 | 4 | 过敏性鼻炎 |
| 盐酸左西替利嗪口服滴剂 | 4 | 过敏性鼻炎 |
| 盐酸氨溴索滴剂 | 3 | 痰液粘稠不易咳出 |
| 氨溴特罗口服溶液 | 3 | 祛痰止咳平喘 |
| 硫酸镁钠钾口服用浓溶液 | 4 | 检查或术前肠道清洁 |
| 丙戊酸钠口服溶液 | 4 | 癫痫 |
| 丙戊酸钠缓释片 | 4 | 癫痫 |
| 拉莫三嗪片 | 4 | 癫痫 |
| 米氮平片 | 4 | 抑郁症 |
| 马来酸氟伏沙明片 | 4 | 抑郁症 |
| 盐酸帕罗西汀肠溶缓释片 | 4 | 抑郁症 |
| 阿立哌唑片 | 4 | 精神分裂症 |
| 盐酸鲁拉西酮片 | 4 | 精神分裂症 |
| 布瑞哌唑片 | 3 | 精神分裂症 |
| 盐酸卡利拉嗪胶囊 | 3 | 精神分裂症 |
| 盐酸美金刚缓释胶囊 | 3 | 阿尔茨海默型痴呆 |
| 米诺地尔搽剂 | 3 | 男性型脱发和斑秃 |
| 米诺地尔泡沫剂 | 3 | 男性型脱发和斑秃 |
| 联苯苄唑溶液 | 3 | 皮肤真菌病 |
有意者请联系：18653879360（微信同号）
可提供吸入制剂（吸入气雾剂、吸入粉雾剂、吸入液体制剂、鼻喷雾剂）CDMO服务，我公司具有15年以上吸入制剂开发、生产经验，可CDMO/CMO，可技术转让。
我公司在CNS领域也有10年以上开发、生产经验，可为客户提供多个产品开发。
外用制剂同样专业，目前我们已经为客户开发米诺地尔搽剂、米诺地尔泡沫剂等产品。
可接受以下剂型的CDMO/CMO委托：
n 吸入混悬液/吸入溶液（瑞士Rommelag 460/321型BFS一体机）（含激素类）
n 吸入粉雾剂（德国瀚辉（HH）胶囊充填机、贮库型充填机）
n 吸入气雾剂（瑞士Pamasol一步法、二步法灌装线）（含激素类）
n 鼻喷雾剂（含激素类）
n 口服液（溶液、混悬液、乳剂）/口腔喷雾剂/滴剂（高速均质，多规格瓶型）
n 外用液体制剂/泡沫剂（防爆设计）
n 外用气雾剂（可充氮，一步法、两步法，防爆设计）
n 小容量注射剂（可充氮，终端灭菌，多规格玻璃安瓿）
有意者请联系：18653879360（微信同号）
可提供吸入气雾剂、吸入粉雾剂、吸入液体制剂、鼻喷雾剂CDMO/CMO服务，可已有项目转让或二次开发，可根据客户立项定制CDMO服务，可接受上述产品CMO业务
